Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Back
Share this video  

BTOG 2019 | Research priorities and trial platforms for lung cancer

Matthew Hatton • 25 Jan 2019
BTOG 2019
Lung Cancer Non-Small Cell Lung Cancer

Matthew Hatton, MSc, MBChB, MRCP, FRCP, FRCR, of the University of Sheffield, Sheffield, UK, discusses the NCRI Lung Cancer Clinical Studies Group research priorities and trial platforms at the British Thoracic Oncology Group (BTOG) 2019 Annual Conference in Dublin, Ireland.

More from Matthew Hatton

0:45
Assessing treatment options for lung cancer with interstitial lung disease
Matthew Hatton • 18 Apr 2024
1:44
Managing lung cancer patients with ILD: the oncology perspective
Matthew Hatton • 18 Apr 2024
1:00
Exploring ILD drugs in lung cancer: research gaps and opportunities
Matthew Hatton • 19 Apr 2024
1:08
Personalized treatment planning for lung cancer with interstitial lung disease
Matthew Hatton • 19 Apr 2024

Related Videos

2:45
Assessing operability in NSCLC: challenges and considerations
Mariana Brandao • 18 Apr 2024
2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
1:47
Assessing follow-up strategies in post-surgical lung cancer: insights from a Phase III trial
Robert Rintoul • 19 Apr 2024
7:37
What is the optimal follow-up for lung cancer long term survivors?
Robert Rintoul • 19 Apr 2024
The content of VJOncology is intended for healthcare professionals